A proto-oncogene BCL6 is up-regulated in the bone marrow microenvironment in multiple myeloma cells

Blood

Volumn 115, Issue 18, 2010, Pages 3772-3775

  Hideshima, Teru ^a   Mitsiades, Constantine ^a   Ikeda, Hiroshi ^a   Chauhan, Dharminder ^a   Raje, Noopur ^a   Gorgun, Gullu ^a   Hideshima, Hiromasa ^a   Munshi, Nikhil C ^a,b   Richardson, Paul G ^a   Carrasco, Daniel R ^a   Anderson, Kenneth C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b Veterans Administration Boston Healthcare   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; I KAPPA B KINASE BETA; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; JANUS KINASE INHIBITOR; NEUTRALIZING ANTIBODY; PROTEIN BCL 6; RECOMBINANT INTERLEUKIN 6; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; BCL6 PROTEIN, HUMAN; DNA BINDING PROTEIN; JANUS KINASE; MESSENGER RNA;

ARTICLE; BONE MARROW; BONE MARROW CELL; CELL GROWTH; COCULTURE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICROENVIRONMENT; MOLECULAR DYNAMICS; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTO ONCOGENE; STROMA CELL; SUPERNATANT; TISSUE MICROARRAY; TUMOR MICROENVIRONMENT; UPREGULATION; CELL PROLIFERATION; DRUG ANTAGONISM; GENETICS; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANTIBODIES, NEUTRALIZING; BLOTTING, WESTERN; BONE MARROW; BONE MARROW CELLS; CELL PROLIFERATION; DNA-BINDING PROTEINS; HUMANS; INTERLEUKIN-6; JANUS KINASES; MULTIPLE MYELOMA; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 77952559263     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-02-270082     Document Type: Article

References (15)

1. Kerckaert JP, Deweindt C, Tilly H, Quief S, Lecocq G, Bastard C. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet. 1993;5(1):66-70. (Pubitemid 23261521)
2. Ye BH, Lista F, Lo Coco F, et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science. 1993;262(5134):747-750. (Pubitemid 23350695)
3. Ci W, Polo JM, Melnick A. B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma. Curr Opin Hematol. 2008;(4):15:381-390.
4. Bereshchenko OR, Gu W, Dalla-Favera R. Acetylation inactivates the transcriptional repressor BCL6. Nat Genet. 2002;32(4):606-613. (Pubitemid 35435172)
5. Lemercier C, Brocard MP, Puvion-Dutilleul F, Kao HY, Albagli O, Khochbin S. Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor. J Biol Chem. 2002;277(24):22045-22052. (Pubitemid 34952359)
6. Polo JM, Dell'Oso T, Ranuncolo SM, et al. Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. Nat Med. 2004;10(12):1329-1335. (Pubitemid 40022714)
7. Cerchietti LC, Yang SN, Shaknovich R, et al. A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo. Blood. 2009;113(15):3397-3405.
8. Hideshima T, Chauhan D, Kiziltepe T, et al. Biologic sequelae of IκB kinase (IKK) inhibition in multiple myeloma: therapeutic implications. Blood. 2009;113(21):5228-5236.
9. Wen D, Nong Y, Morgan JG, et al. A selective small molecule IκB kinase β inhibitor blocks nuclear factor κB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells. J Pharmacol Exp Ther. 2006;317(3):989-1001.
10. Hideshima T, Catley L, Yasui H, et al. Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells. Blood. 2006;107(10):4053-4062. (Pubitemid 43726814)
11. Hideshima T, Chauhan D, Teoh G, et al. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6. Clin Cancer Res. 2000;6(3):1180-1189. (Pubitemid 30159383)
12. Carrasco DR, Sukhdeo K, Protopopov M, et al. The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis. Cancer Cell. 2007;11(4):349-360.
13. Hideshima T, Catley L, Raje N, et al. Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells. Br J Haematol. 2007;138(6):783-791.
14. Chauhan D, Uchiyama H, Akbarali Y, et al. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-κB. Blood. 1996;87(3):1104-1112. (Pubitemid 26043538)
15. Hideshima T, Ikeda H, Chauhan D, et al. Bortezomib induces canonical nuclear factor-κB activation in multiple myeloma cells. Blood. 2009;114(5):1046-1052.